• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Surgery

Quick Take: Association of Surgical Intervention for Adhesive Small-Bowel Obstruction With the Risk of Recurrence

byDonna LeetandAliya Ramjaun
February 8, 2019
in Surgery
Reading Time: 2 mins read
Quick Take: Association of Surgical Intervention for Adhesive Small-Bowel Obstruction With the Risk of Recurrence
Share on FacebookShare on TwitterShare on LinkedIn

Surgeons are often presented with the challenge of determining the appropriate management for adhesive small bowel obstruction (aSBO). While non-operative management leaves the responsible adhesions in place, operative management may create new adhesions. Previous studies have suggested that nonoperative management of aSBO may be associated with a greater risk of recurrence, but they have been limited by heterogeneity of the patient cohort. In this propensity-matched retrospective cohort study, 27,904 patients admitted to the hospital with a primary diagnosis of adhesive or unspecified intestinal obstruction (index admission) were studied to compare the cumulative incidence of recurrence of aSBO between patients who underwent operative management at the index admission compared to patients who underwent nonoperative management. Overall, 22.2% of patients underwent operative management at their index admission. These patients were slightly younger (mean age 60.2 years vs. 61.5 years), more likely to be female (57.8% vs. 49.2%), and had fewer comorbidities (low burden, 6.2% vs. 4.2%) than patients who received nonoperative management. Researchers found that patients who underwent operative management at the index admission had a lower risk of recurrence than those undergoing nonoperative management after propensity matching (13.0% vs. 21.3% respectively, HR 0.62, 95% CI 0.56 to 0.68, p<0.001). Furthermore, regardless of the method used to manage previous episodes, patients who underwent operative management during their second and third episodes of aSBO had a significantly lower risk of subsequent recurrence than those who underwent nonoperative management (relative risk reduction [RRR] 51% for second episode, 95% CI 30% to 61%, RRR 55% for third episode, 95% CI 35% to 70%). Importantly, this study suggests that surgical intervention may decrease, not increase, the risk of recurrent aSBO.

Click to read the study in JAMA Surgery

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

2 Minute Medicine Rewind February 4, 2019

Patient Basics: Abdominal Adhesions

Tags: Adhesionssmall bowel obstruction
Previous Post

Behavioral dysregulation in infancy predicts later child mental health

Next Post

Porphyria recurrence in a transplant recipient illustrates the need for genetic screening of related organ donors

RelatedReports

Computed tomography improves diagnostic certainty in the emergency department
Weekly Rewinds

2 Minute Medicine Rewind February 4, 2019

February 8, 2019
Health A to Z

Patient Basics: Abdominal Adhesions

November 30, 2014
Next Post
Spleen elastography may be effective in the diagnosis of portal hypertension

Porphyria recurrence in a transplant recipient illustrates the need for genetic screening of related organ donors

Quick Take: Cadazolid for the treatment of Clostridium difficile infection: results of two double-blind, placebo-controlled, non-inferiority, randomised phase 3 trials

Quick Take: Cadazolid for the treatment of Clostridium difficile infection: results of two double-blind, placebo-controlled, non-inferiority, randomised phase 3 trials

Primary care utilization associated with increased high-value care

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Preoperative self-preparation for total knee arthroplasty is multifactorial and can be optimized by targeting external support and internal motivation
  • Artificial intelligence (AI)-powered mental health app demonstrated improved social well-being among users
  • Children with intellectual and developmental disabilities have increased risks of depression and anxiety
License Content
Terms of Use | Disclaimer
Cookie Policy
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Limited-time Deep research trial
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.